It has been recently revealed in a research that the newest details of the stem cell therapy have proved to be really viable for use in the medical field. It was further added that these clinical trials have shown early signs of success.
It was said that the stem cells that have been acquired from human embryos that have been grown in the labs. The best is that that they are of the best quality and may be used for further clinical trial and support in the time to come. The stem cells used earlier have been of lesser quality than this and have proved to be incapable and have had to be modified to become the `clinical grade'.
The ESC's are however of the view that these stem cells come directly from the patients, and are totally un-tampered with, making them absolutely useful for regenerative research use. They don't have the faintest hints of animal products added to them, like other researchers have to for the stimulation of the growth of the cells.
It was revealed by Professor Peter Braude, the lead author of the study that "The key here is that these are clinical grade lines, they have been set up from the beginning as lines that do not contain animal products and have not got animal products coming into contact with them".
There has been the development of similar cells at the Manchester University, and it is hoped that the same shall be donated to the stem cell bank soon. Professor Braude revealed that this discovery and development has taken them a long time of research for ten years, which was full of failures and disappointments, but eventually paid off well.